These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
425 related articles for article (PubMed ID: 29030021)
1. Hypoxic volume evaluated by Sato J; Kitagawa Y; Watanabe S; Asaka T; Ohga N; Hirata K; Shiga T; Satoh A; Tamaki N Int J Oral Maxillofac Surg; 2018 May; 47(5):553-560. PubMed ID: 29030021 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of preoperative metabolic tumour volume and total lesion glycolysis measured by (18)F-FDG PET/CT in squamous cell carcinoma of the oral cavity. Ryu IS; Kim JS; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY Eur J Nucl Med Mol Imaging; 2014 Mar; 41(3):452-61. PubMed ID: 24081448 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma. Kim JW; Oh JS; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088 [TBL] [Abstract][Full Text] [Related]
5. Total lesion glycolysis: a possible new prognostic parameter in oral cavity squamous cell carcinoma. Abd El-Hafez YG; Moustafa HM; Khalil HF; Liao CT; Yen TC Oral Oncol; 2013 Mar; 49(3):261-8. PubMed ID: 23036774 [TBL] [Abstract][Full Text] [Related]
6. Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma. Sato J; Kitagawa Y; Yamazaki Y; Hata H; Asaka T; Miyakoshi M; Okamoto S; Shiga T; Shindoh M; Kuge Y; Tamaki N Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2031-41. PubMed ID: 24867258 [TBL] [Abstract][Full Text] [Related]
7. Prognostic role of metabolic parameters of (18)F-FDG PET-CT scan performed during radiation therapy in locally advanced head and neck squamous cell carcinoma. Min M; Lin P; Lee MT; Shon IH; Lin M; Forstner D; Bray V; Chicco A; Tieu MT; Fowler A Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):1984-94. PubMed ID: 26081941 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of Lee JR; Almuhaimid TM; Roh JL; Oh JS; Kim SJ; Kim JS; Choi SH; Nam SY; Kim SY J Surg Oncol; 2018 Sep; 118(4):644-650. PubMed ID: 30132891 [TBL] [Abstract][Full Text] [Related]
9. FDG-PET/CT Predicts Outcome in Oropharingeal Carcinoma Patients Undergoing Intensity Modulated Radiation Therapy with Dose Escalation to FDG-avid Tumour Volumes. Mapelli P; Broggi S; Incerti E; Alongi P; Kirienko M; Fiorino C; Dell Oca I; Fallanca F; Vanoli EG; Di Muzio NG; Gianolli L; Picchio M Curr Radiopharm; 2017 Aug; 10(2):102-110. PubMed ID: 28412923 [TBL] [Abstract][Full Text] [Related]
10. The Volume-metabolic Combined Parameters from (18)F-FDG PET/CT May Help Predict the Outcomes of Cervical Carcinoma. Sun Y; Lu P; Yu L Acad Radiol; 2016 May; 23(5):605-10. PubMed ID: 26853968 [TBL] [Abstract][Full Text] [Related]
11. Assessment of biological parameters in head and neck cancer based on in vivo distribution of Cegla P; Kazmierska J; Gwozdz S; Czepczynski R; Malicki J; Cholewinski W Tumori; 2020 Feb; 106(1):33-38. PubMed ID: 31446858 [TBL] [Abstract][Full Text] [Related]
12. 18F-fluoromisonidazole PET uptake is correlated with hypoxia-inducible factor-1α expression in oral squamous cell carcinoma. Sato J; Kitagawa Y; Yamazaki Y; Hata H; Okamoto S; Shiga T; Shindoh M; Kuge Y; Tamaki N J Nucl Med; 2013 Jul; 54(7):1060-5. PubMed ID: 23699668 [TBL] [Abstract][Full Text] [Related]
13. Clinical significance of pretreatment metabolic tumor volume and total lesion glycolysis in hypopharyngeal squamous cell carcinomas. Roh JL; Kim JS; Kang BC; Cho KJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY J Surg Oncol; 2014 Dec; 110(7):869-75. PubMed ID: 25088392 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma. Son SH; Kang SM; Jeong SY; Lee SW; Lee SJ; Lee J; Ahn BC Clin Nucl Med; 2016 Jun; 41(6):e266-73. PubMed ID: 27055144 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of pretreatment 18F-FDG PET/CT parameters including visual evaluation in patients with head and neck squamous cell carcinoma. Koyasu S; Nakamoto Y; Kikuchi M; Suzuki K; Hayashida K; Itoh K; Togashi K AJR Am J Roentgenol; 2014 Apr; 202(4):851-8. PubMed ID: 24660716 [TBL] [Abstract][Full Text] [Related]
16. Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F-FDG PET/CT, predict the recurrence of endometrial cancer. Shim SH; Kim DY; Lee DY; Lee SW; Park JY; Lee JJ; Kim JH; Kim YM; Kim YT; Nam JH BJOG; 2014 Aug; 121(9):1097-106; discussion 1106. PubMed ID: 24397772 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma. Hyun SH; Choi JY; Shim YM; Kim K; Lee SJ; Cho YS; Lee JY; Lee KH; Kim BT Ann Surg Oncol; 2010 Jan; 17(1):115-22. PubMed ID: 19826877 [TBL] [Abstract][Full Text] [Related]
18. Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers. Lin P; Min M; Lee M; Holloway L; Forstner D; Bray V; Fowler A Eur J Nucl Med Mol Imaging; 2017 May; 44(5):801-811. PubMed ID: 28004135 [TBL] [Abstract][Full Text] [Related]
19. Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value. Satoh Y; Onishi H; Nambu A; Araki T Radiology; 2014 Jan; 270(1):275-81. PubMed ID: 24029640 [TBL] [Abstract][Full Text] [Related]
20. Use of Rudžianskas V; Korobeinikova E; Rudžianskienė M; Jaselskė E; Adlienė D; Šedienė S; Kulakienė I; Padervinskis E; Jurkienė N; Juozaitytė E Medicina (Kaunas); 2018 Dec; 54(6):. PubMed ID: 30544718 [No Abstract] [Full Text] [Related] [Next] [New Search]